Australia: Oventus to raise A$6.65m as Covid-19 buffer

Mel Bridges, chairman, Oventus

Sleep disorder device manufacturer Oventus has joined the list of Australian companies to raise money in the equity markets as a buffer against the Covid-19 pandemic. So far, Australian companies have raised almost US$14bn to shore up their capital, according to Reuters. Oventus has raised A$4.65m (US$3m) from a placement to existing and new institutional…

You must be a HMI Subscriber to view this content.

Subscribe Now »